TherapeuticsMD | TXMD - Sales Revenues


TherapeuticsMD reported $234K in Sales Revenues for its fiscal quarter ending in June of 2024.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Alterity Therapeutics Limited AUD 11.38K 10.23K Dec/2022
Cipla INR 75.18B 710M Dec/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 1.89M 631K Sep/2025
CSL USD 8.33B 4.79B Dec/2025
Grifols EUR 2.34B 159.69M Mar/2026
Novo Nordisk DKK 12.53B 560M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
TherapeuticsMD USD 234K 79K Jun/2024